EA200601449A1 - Применение агомелатина для получения лекарственных средств, предназначенных для лечения нарушений сна у пациента с депрессией - Google Patents

Применение агомелатина для получения лекарственных средств, предназначенных для лечения нарушений сна у пациента с депрессией

Info

Publication number
EA200601449A1
EA200601449A1 EA200601449A EA200601449A EA200601449A1 EA 200601449 A1 EA200601449 A1 EA 200601449A1 EA 200601449 A EA200601449 A EA 200601449A EA 200601449 A EA200601449 A EA 200601449A EA 200601449 A1 EA200601449 A1 EA 200601449A1
Authority
EA
Eurasian Patent Office
Prior art keywords
depression
patient
treatment
agomelatin
sleep disorders
Prior art date
Application number
EA200601449A
Other languages
English (en)
Other versions
EA014288B1 (ru
Inventor
Брюно Делалло
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36200255&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601449(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200601449A1 publication Critical patent/EA200601449A1/ru
Publication of EA014288B1 publication Critical patent/EA014288B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Настоящее изобретение относится к применению агомелатина, или N-[2-(7-метокси-1-нафтил)этил]ацетамида, для приготовления лекарственных средств, предназначенных для лечения нарушений сна у пациента с депрессией.
EA200601449A 2005-09-09 2006-09-08 Применение агомелатина для лечения нарушений сна у пациентов с депрессией EA014288B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509207A FR2890562B1 (fr) 2005-09-09 2005-09-09 Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime

Publications (2)

Publication Number Publication Date
EA200601449A1 true EA200601449A1 (ru) 2007-04-27
EA014288B1 EA014288B1 (ru) 2010-10-29

Family

ID=36200255

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601449A EA014288B1 (ru) 2005-09-09 2006-09-08 Применение агомелатина для лечения нарушений сна у пациентов с депрессией

Country Status (26)

Country Link
US (1) US20070060655A1 (ru)
EP (2) EP1762237A1 (ru)
JP (1) JP2007077148A (ru)
KR (2) KR20070029608A (ru)
CN (1) CN1927193B (ru)
AP (1) AP2008004379A0 (ru)
AR (1) AR056063A1 (ru)
AU (1) AU2006209372A1 (ru)
BR (1) BRPI0603762A (ru)
CA (1) CA2558762A1 (ru)
EA (1) EA014288B1 (ru)
FR (1) FR2890562B1 (ru)
GE (1) GEP20094602B (ru)
GT (1) GT200600409A (ru)
HK (1) HK1100481A1 (ru)
MA (1) MA28506B1 (ru)
MX (1) MXPA06010233A (ru)
NO (1) NO20064050L (ru)
NZ (1) NZ549726A (ru)
PE (1) PE20070333A1 (ru)
SG (1) SG146451A1 (ru)
TW (1) TW200800148A (ru)
UA (1) UA81573C2 (ru)
UY (1) UY29777A1 (ru)
WO (1) WO2007028905A1 (ru)
ZA (1) ZA200607531B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918370B1 (fr) * 2007-07-02 2009-08-28 Servier Lab Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2918372B1 (fr) * 2007-07-02 2009-08-28 Servier Lab Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN102190594A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀氯化氢水合物及其制备方法
CN102190595A (zh) * 2010-03-17 2011-09-21 上海医药工业研究院 阿戈美拉汀溴化氢水合物及其制备方法
CN101991559B (zh) * 2010-11-25 2012-04-18 天津市汉康医药生物技术有限公司 一种稳定的阿戈美拉汀胶囊药物组合物
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
WO2013119605A1 (en) * 2012-02-07 2013-08-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Promoting sleep using at1 receptor blockers
CN102552211B (zh) * 2012-02-16 2013-07-17 福建广生堂药业股份有限公司 一种阿戈美拉汀的制剂组合物及其制备方法
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
PT2810656T (pt) 2013-06-06 2017-11-13 Zentiva As Formulações de agomelatina compreendendo agomelatina na forma de cocristais
EP2856934A1 (en) * 2013-10-04 2015-04-08 Les Laboratoires Servier Biomarkers for the prediction of long term remission in depression
CN103655499B (zh) * 2013-12-23 2015-07-22 天津泰普药品科技发展有限公司 一种稳定的晶x型阿戈美拉汀片剂及其制备方法
CN103690499B (zh) * 2013-12-23 2015-05-06 天津泰普药品科技发展有限公司 一种稳定的晶i型阿戈美拉汀片剂及其制备方法
CN104523639B (zh) * 2014-12-11 2017-03-22 扬子江药业集团四川海蓉药业有限公司 一种阿戈美拉汀片剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
CA2551637A1 (en) * 2003-12-24 2005-07-14 Sepracor Inc. Melatonin combination therapy for improving sleep quality
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
US7358395B2 (en) * 2005-08-03 2008-04-15 Les Laboratories Servier Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7635721B2 (en) * 2005-08-03 2009-12-22 Les Laboratoires Servier Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US7645905B2 (en) * 2005-08-03 2010-01-12 Les Laboratoires Servier Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
SG146451A1 (en) 2008-10-30
KR20080103043A (ko) 2008-11-26
ZA200607531B (en) 2008-05-28
US20070060655A1 (en) 2007-03-15
AR056063A1 (es) 2007-09-19
JP2007077148A (ja) 2007-03-29
FR2890562A1 (fr) 2007-03-16
UY29777A1 (es) 2006-10-31
FR2890562B1 (fr) 2012-10-12
WO2007028905A1 (fr) 2007-03-15
EP1762237A1 (fr) 2007-03-14
MXPA06010233A (es) 2007-03-08
BRPI0603762A (pt) 2007-05-15
CA2558762A1 (fr) 2007-03-09
NO20064050L (no) 2007-03-12
AP2008004379A0 (en) 2008-04-30
CN1927193B (zh) 2011-01-05
EP2295050A1 (fr) 2011-03-16
HK1100481A1 (en) 2007-09-21
MA28506B1 (fr) 2007-04-03
AU2006209372A1 (en) 2007-03-29
NZ549726A (en) 2008-03-28
GEP20094602B (en) 2009-02-10
PE20070333A1 (es) 2007-06-02
TW200800148A (en) 2008-01-01
GT200600409A (es) 2007-04-30
EA014288B1 (ru) 2010-10-29
CN1927193A (zh) 2007-03-14
UA81573C2 (en) 2008-01-10
KR20070029608A (ko) 2007-03-14

Similar Documents

Publication Publication Date Title
EA200601449A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения нарушений сна у пациента с депрессией
EA200700574A3 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения генерализированного тревожного расстройства
EA200600600A1 (ru) Применение агомелатина для приготовления лекарственных средств, предназначенных для лечения маниакально-депрессивных расстройств
EA200702318A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения синдрома смита-магениса
EA201201123A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения обсессивно-компульсивного расстройства (окр)
EA200702317A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения перивентрикулярной лейкомаляции
EA200601450A1 (ru) Новая комбинация агомелатина и тиморегулирующего средства и фармацевтические композиции, которые её содержат
CU20070232A7 (es) Utilización de la agomelatina para la obtención de medicamentos destinados al tratamiento de los trastornos bipolares

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU